The impact of the war has quickly gone from bad to potentially catastrophic. Here’s the latest reporting and analysis.
SINGAPORE, SINGAPORE, SINGAPORE, March 20, 2026 /EINPresswire.com/ -- As we navigate the sophisticated landscape of ...
Looking to enter India’s ₹1,446 crore glucagon-like peptide (GLP-1) market, Hyderabad-based pharma major Dr Reddy’s Laboratories (DRL) has launched its semaglutide generic, Obeda, for Type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results